We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Consensus Estimate for revenues is pegged at $229.9 million, indicating 17.6% growth from the year-ago fiscal quarter’s reported figure. The top line is likely to have benefited from customer wins, a solid expansion within the existing customer base, health care vertical, contributions from numerous multi-year deals, strength across subscription business, software robots and automation cloud.
Rising expenses (partly driven by headcount additions and annual employee merit cycle) are likely to have weighed on PATH’s bottom line. The Zacks Consensus Estimate for the same is pegged at a loss of 11 cents per share. UiPath had registered earnings of a penny in the year-ago fiscal quarter.
Our proven model does not conclusively predict an earnings beat for UiPath this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. You can see the complete list of today’s Zacks #1 Rank stocks here.
UiPath has an Earnings ESP of 0.00% and a Zacks Rank #3.
Recent Performances of Some Business Services Companies
Equifax (EFX - Free Report) reported mixed second-quarter 2022 results, wherein earnings beat estimates but revenues missed the same.
EFX’s adjusted earnings of $2.09 per share beat the Zacks Consensus Estimate by 3% and improved 5.6% on a year-over-year basis. Revenues of $1.32 billion missed the consensus estimate marginally but improved 6.6% year over year.
IQVIA Holdings (IQV - Free Report) reported solid second-quarter 2022 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate.
IQV’s adjusted earnings per share of $2.44 beat the consensus mark by 2.1% and improved 15% on a year-over-year basis. Total revenues of $3.54 billion outpaced the consensus estimate by 1.2% and increased 3% year over year.
Omnicom Group (OMC - Free Report) reported impressive second-quarter 2022 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate.
OMC’s earnings of $1.68 per share beat the consensus mark by 7.7% and increased 15.1% year over year, driven by a strong margin performance. Total revenues of $3.6 billion surpassed the consensus estimate by 4.4% but declined slightly year over year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
UiPath (PATH) to Report Q2 Earnings: What's in the Offing?
UiPath, Inc. (PATH - Free Report) is scheduled to release second-quarter fiscal 2023 results on Sep 6, after market close.
Let’s check out the expectations in detail.
Q2 Expectations
The Zacks Consensus Estimate for revenues is pegged at $229.9 million, indicating 17.6% growth from the year-ago fiscal quarter’s reported figure. The top line is likely to have benefited from customer wins, a solid expansion within the existing customer base, health care vertical, contributions from numerous multi-year deals, strength across subscription business, software robots and automation cloud.
Rising expenses (partly driven by headcount additions and annual employee merit cycle) are likely to have weighed on PATH’s bottom line. The Zacks Consensus Estimate for the same is pegged at a loss of 11 cents per share. UiPath had registered earnings of a penny in the year-ago fiscal quarter.
UiPath, Inc. Price and EPS Surprise
UiPath, Inc. price-eps-surprise | UiPath, Inc. Quote
What Our Model Says
Our proven model does not conclusively predict an earnings beat for UiPath this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. You can see the complete list of today’s Zacks #1 Rank stocks here.
UiPath has an Earnings ESP of 0.00% and a Zacks Rank #3.
Recent Performances of Some Business Services Companies
Equifax (EFX - Free Report) reported mixed second-quarter 2022 results, wherein earnings beat estimates but revenues missed the same.
EFX’s adjusted earnings of $2.09 per share beat the Zacks Consensus Estimate by 3% and improved 5.6% on a year-over-year basis. Revenues of $1.32 billion missed the consensus estimate marginally but improved 6.6% year over year.
IQVIA Holdings (IQV - Free Report) reported solid second-quarter 2022 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate.
IQV’s adjusted earnings per share of $2.44 beat the consensus mark by 2.1% and improved 15% on a year-over-year basis. Total revenues of $3.54 billion outpaced the consensus estimate by 1.2% and increased 3% year over year.
Omnicom Group (OMC - Free Report) reported impressive second-quarter 2022 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate.
OMC’s earnings of $1.68 per share beat the consensus mark by 7.7% and increased 15.1% year over year, driven by a strong margin performance. Total revenues of $3.6 billion surpassed the consensus estimate by 4.4% but declined slightly year over year.